... the level of individual molecules in living animals, and also because it can be easily extended to other chemotherapy drugs and tumor systems to give a potentially global view of factors that mediate ...
... and analyzing many thousands of living cells to reveal exactly how a chemotherapy drug affects each one. For research student Ariel Cohen, together with Naama Geva-Zatorsky and Eran ...
A chemotherapy drug that is supposed to help save cancer patients' lives, instead resulted in life-threatening and sometimes fatal allergic reactions. A new study from the Research on Adverse Drug ...
... to one another. The animals were then given one of two types of common chemotherapy drugs, melphalan and temozolomide.
“We found that the response to ADH-1 in combination with melphalan was more ...
... /Oncology annual meeting on May 15.
"Traditional chemotherapy drugs kill any fast-growing ... by giving more NK cells or by giving more toxic chemotherapy," says Lee. "Instead, we want to marry the two ...
Men with a certain type of prostate cancer have been shown to respond to a new chemotherapy drug, Sagopilone, plus prednisone in an international trial led by Oregon Health & Science University Cancer ...
... is that the tumours either fail to respond or stop responding over time to various chemotherapy drugs," Pelletier said. "One reasonable explanation for why this happens is the normal process of ...
... technique that has the potential to deliver cancer-fighting drugs to diseased areas within hours, as opposed ... each PEG ligand, molecules of a photodynamic chemotherapy drug (Pc 4) are attached to the Au ...
... action. One part breaks down into active fluorouracil (5-FU) once it is in the body. 5-FU is a chemotherapy drug often used to treat colorectal and other cancers.
Another part of S ...
... to them. The problem is well documented for antibiotics, although not confined to them. Chemotherapy drugs that were once highly effective when first used against a particular cancer now are often ...
... the University of California, San Diego (UC SD) in La Jolla have found evidence explaining why a common chemotherapy drug, cisplatin, may not always work for every cancer patient. They ...
... at the University of California, San Diego (UC SD) in La Jolla have found evidence explaining why a common chemotherapy drug, cisplatin, may not always work for every cancer patient...
... Dr. Kerbel. "Further, our findings provide a potential explanation of why not all chemotherapy drugs will necessarily have their efficacy enhanced by the addition of an antiangiogenic agent when the ...
... after first-line treatment. Half the women received a combination therapy of trabectedin and a chemotherapy drug called pegylated liposomal doxorubicin. The other half received the chemotherapy drug ...
... the form that ascorbic acid (vitamin C) takes to enter cells.
They found to their surprise that every chemotherapy drug they tested – which included targeted agents like Gleevec – did not work as ...
